With a reputation for innovation, COPAN Diagnostics is the leading manufacturer of collection and transport systems in the world. COPAN’s collaborative approach to innovation in preanalytics has resulted in patented FLOQSwabs™, ESwab™ and UTM™ Viral Transport Media, and laboratory automation, WASP®DT and WASPLab™ have been proven to advance the quality of traditional and contemporary... Read More
Founded over 60 years ago, Dynex Technologies, Inc., is a leading designer and manufacturer of fully-automated ELISA microplate workstations, laboratory instruments and associated consumables and accessories, seamlessly integrating advanced detection with fully-automated sample handling.
SOBIODA conceives, develops, manufactures reagents and devices for the in-vitro medical diagnosis. Their range of reagents is adapted to the needs of laboratories in different domains of the medical analysis, the research and the teaching.
Inova Diagnostics, Inc.
Inova Diagnostics, Inc., part of the Werfen Group, has been the trusted source for autoimmune disease diagnostics for over 20 years. Most of Inova Diagnostic's’s work centers on the detection of autoantibodies. Inova Diagnostics strives to be in the forefront of development of new tests and technologies that aid in the diagnosis of autoimmune disease.
Established in 1977 in Palombara Sabina Rome, Italy. The company was born with a strong motivation towards the technological innovation. In time DAS has operated in many different fields of application, such as: Pediatrics, Industrial applications, Environmental pollution, Diagnostics and Automation for the manipulation of samples to be analyzed and other. Today with its own strong technical... Read More
AlphaDia belongs to the pioneers of the membrane technology in autoimmune and gastroenterology diagnostics with their AlphaDia-Dot product line. Their easy to use Dot-panel assays allow the detection and identification of autoimmune antibodies and the profiling of different systemic autoimmune diseases.
Critical Diagnostics was founded in 2004 and is focused on the discovery, development, and commercialization of novel biomarkers in cardiovascular diseases . The lead product, the Presage® ST2 Assay , has received FDA clearance and is CE Marked in Europe. This simple, non-invasive test measures for soluble ST2 in the blood, which can aid physicians in risk assessment of heart failure... Read More